Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring-guided adalimumab dosing in children with Crohn's disease
MOH_2017-05-01_000368Phase 4Active, not recruiting
- Sponsor
- ד"ר עמית אסא
- Start
- May 2015
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of adalimumab in Crohn's disease (2 arms), sponsored by ד"ר עמית אסא. Primary endpoint: Maintenance of remission without loss of response. Started May 2015; status: active, not recruiting.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on MOH_2017-05-01_000368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-01_000368.